Hematology
Sickle Cell Disease
Underfunded, undertreated, and mismanaged pain crises. A system-wide failure.
Last updated April 15, 2026
Who is most affected
- Approximately 100,000 Americans, predominantly of African descent
- Patients of Caribbean, Mediterranean, Middle Eastern, and Indian ancestry
- Carriers of sickle cell trait (often confused with disease)
- Children transitioning to adult care, where treatment quality often drops
Key disparities
- Federal research funding lags far behind comparable rare diseases
- Pain crises are routinely undertreated due to bias and opioid stigma
- Emergency department wait times for sickle cell pain are documented as longer
- Confusion between sickle cell trait and disease has led to wrong treatment and denied care
Placeholder content. Real article forthcoming.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
What a sickle cell pain crisis actually feels like
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Trait vs. disease, and why providers still get it wrong
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
What you can ask at your next appointment
- Placeholder action item one.
- Placeholder action item two.
- Placeholder action item three.